Compound Guide

Semaglutide Testing Guide: Purity, Identity & Verification

Updated March 2026 · 18 min read · 5,000 words · By KORECOA Research Team

Table of Contents

  1. Why Semaglutide Testing Matters
  2. The Semaglutide Market in 2026
  3. Quality Risks Specific to Semaglutide
  4. Testing Methods for Semaglutide
  5. Why Blind Testing Is the Gold Standard
  6. Reading a Semaglutide COA
  7. Tirzepatide and Other GLP-1s
  8. Finding Verified Semaglutide Sources
  9. FAQ

Semaglutide has become the most talked-about peptide in the world. Originally developed by Novo Nordisk as Ozempic (for diabetes) and Wegovy (for weight management), the compound has spawned a massive research market. And with that demand comes a corresponding surge in quality concerns — counterfeit products, underdosed vials, substitutions, and fabricated COAs.

If you're buying, selling, or researching Semaglutide, independent testing isn't optional. It's the only way to know what you actually have. This guide covers everything specific to Semaglutide verification: the unique testing challenges, what to look for on a COA, why blind testing matters, and how to find verified sources.

1. Why Semaglutide Testing Matters More Than Other Peptides

Semaglutide occupies a unique position in the peptide market. It's a modified GLP-1 receptor agonist with a complex structure — 31 amino acids with a C-18 fatty acid chain attached via a linker, giving it a molecular weight of 4,113.58 Da. This complexity makes it expensive to synthesize correctly, which creates economic incentives for manufacturers to cut corners.

The compound is also one of the most counterfeited peptides in circulation. Because demand is so high and buyers are often willing to pay premium prices, bad actors have strong motivation to sell substandard or fake product. Reports from independent testing services consistently show that a meaningful percentage of "Semaglutide" samples fail identity confirmation — meaning they contain a different compound entirely.

2. The Semaglutide Market in 2026

The GLP-1 receptor agonist market continues to expand. Novo Nordisk's branded products (Ozempic, Wegovy, Rybelsus) generated tens of billions in revenue, and the research compound market has grown alongside it. Compounding pharmacies, research institutions, and the broader research community represent significant demand for analytical-grade Semaglutide.

Multiple Chinese manufacturers now produce research-grade Semaglutide, with quality ranging from excellent to concerning. The price has dropped considerably as more manufacturers have entered the market, but lower prices haven't eliminated quality problems — they may have amplified them as manufacturers compete on cost.

3. Quality Risks Specific to Semaglutide

Wrong Compound Entirely

The most serious risk. Some vendors sell other peptides labeled as Semaglutide. Common substitutes include cheaper GLP-1 analogs, truncated Semaglutide fragments, or entirely unrelated peptides. Only mass spectrometry (LC-MS) can catch this — the molecular weight of 4,113.58 Da is distinctive and easy to verify.

Low Purity

Semaglutide synthesis is challenging due to the fatty acid modification. Incomplete conjugation, deletion sequences, and deprotection byproducts are common impurities. Legitimate manufacturers typically achieve 95-99% purity. Samples below 90% indicate serious manufacturing issues.

Content Discrepancies

A vial labeled "5mg" should contain approximately 5mg of total lyophilized material. After accounting for counterions and moisture, the net Semaglutide content is typically 65-80% of the labeled weight. But some products contain significantly less material than labeled — sometimes half or less. This means you're paying for 5mg and getting 2.5mg.

Degradation

Semaglutide can degrade during storage, especially if exposed to heat, light, or moisture. Degradation products may not be visible to the naked eye — the powder might look fine but contain significantly reduced active content. HPLC detects degradation as additional peaks in the chromatogram.

4. Testing Methods for Semaglutide

LC-MS Identity Confirmation

The essential first test. LC-MS measures the molecular weight of the compound in your sample. Semaglutide's theoretical molecular weight is 4,113.58 Da. An observed mass within ±2 Da confirms identity. This test alone eliminates the most dangerous quality failure — receiving the wrong compound.

RP-HPLC Purity Analysis

Standard reversed-phase HPLC at 220nm UV detection provides the purity percentage and chromatographic profile. For Semaglutide, look for a single dominant peak with retention time consistent with the fatty-acid-modified structure (it's more hydrophobic than most peptides due to the C-18 chain, so it elutes later in a standard gradient).

Amino Acid Analysis

For deeper characterization, AAA confirms the amino acid composition matches Semaglutide's sequence and provides accurate net peptide content. This is the most reliable way to determine how much active Semaglutide is actually in the vial.

Endotoxin Testing

Critical if the compound will be reconstituted and injected. The LAL test detects bacterial endotoxins at very low levels. Any Semaglutide intended for subcutaneous injection should pass endotoxin screening before use.

5. Why Blind Testing Is the Gold Standard

Blind testing means the laboratory doesn't know what the sample is supposed to be. They analyze it and tell you what they find. This is the gold standard for Semaglutide verification, and here's why it matters.

In standard testing, the client tells the lab "this is Semaglutide, please confirm." The lab then looks for evidence that supports that claim. While professional labs won't fabricate results, there's an inherent framing effect — the analyst is looking to confirm rather than discover.

In blind testing, the lab receives a sample with no preconceptions. They run it through LC-MS and identify the compound based purely on the data. If it's Semaglutide, they'll find Semaglutide. If it's something else, they'll tell you what it actually is. No framing effect, no confirmation bias.

KORECOA offers dedicated GLP-1 blind testing that covers Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide. The lab identifies the compound without being told what to expect.

Blind Test vs. Specified Test

A specified test says "confirm this is Semaglutide." A blind test says "tell me what this is." For high-value compounds like Semaglutide where counterfeiting is common, blind testing provides stronger assurance. It's slightly more expensive because the lab needs to screen against a broader range of possible compounds, but the added confidence is worth it.

6. Reading a Semaglutide COA

What to Check First: Identity

Look at the LC-MS result. The observed molecular weight should be within ±2 Da of 4,113.58. If it's significantly off, stop — the compound is not Semaglutide regardless of what other numbers look like.

Purity Assessment

Look at both the percentage and the chromatogram. A clean chromatogram with one dominant peak at 98%+ purity is ideal. Multiple peaks or a purity below 95% raise questions about manufacturing quality. Compare the chromatogram shape to reference chromatograms if available — Semaglutide should show a consistent retention time and peak shape.

Verification

Can you verify the COA independently? A QR code linking to a verification database (like KORECOA's verification portal) provides confidence the COA is authentic. Without verification, you're trusting a PDF that anyone could create.

7. Tirzepatide and Other GLP-1 Receptor Agonists

Semaglutide isn't alone in the GLP-1 space. Tirzepatide (Eli Lilly's Mounjaro/Zepbound), Retatrutide, and Cagrilintide represent the next wave of GLP-1-related compounds, and they face similar verification challenges.

Tirzepatide (MW: ~4,813.45 Da) is a dual GIP/GLP-1 receptor agonist with even greater complexity than Semaglutide. Its molecular weight is sufficiently different from Semaglutide that LC-MS easily distinguishes between the two — which is important because cross-substitution between these compounds has been reported.

Retatrutide is a triple agonist (GIP/GLP-1/glucagon) that represents the cutting edge of this compound class. As a newer compound, verification is especially important because manufacturing experience is less established.

KORECOA's GLP-1 blind test screens for all major compounds in this class, identifying which specific agonist is present without requiring the client to specify.

8. Finding Verified Semaglutide Sources

The most reliable way to find quality Semaglutide is to look for vendors who invest in independent testing. The BestPeptideSource.com supplier directory lists vendors with their testing status, making it easy to identify sources that have been independently verified.

Vendors participating in the KORECOA Certified Vendor Program commit to ongoing independent testing of their Semaglutide batches. The KORECOA VERIFIED seal on a product listing means that specific batch has been tested and passed at an accredited Korean laboratory.

Test Your Semaglutide

GLP-1 blind testing from accredited Korean labs. We tell you what it is — not the other way around.

Order Blind Test →

9. Frequently Asked Questions

How can I tell if my Semaglutide is real without testing?

You can't. Not reliably. Visual inspection, reconstitution behavior, and even physiological response aren't reliable indicators of identity or purity. The only way to know for certain is analytical testing with mass spectrometry.

What's a normal purity range for research Semaglutide?

Quality manufacturers typically achieve 95-99%+ purity. Below 95% raises concerns about manufacturing quality. Below 90% is substandard. These ranges assume testing by a standard RP-HPLC method at 220nm.

Is Semaglutide legal to purchase?

Regulations vary by jurisdiction. In many countries, Semaglutide can be purchased for research purposes under "Research Use Only" designations. KORECOA provides analytical testing services for RUO compounds and does not provide legal advice. Consult legal counsel regarding regulations in your specific jurisdiction.

How should Semaglutide be stored?

Lyophilized (freeze-dried) Semaglutide should be stored at -20°C for long-term storage or 2-8°C for shorter periods. Protect from light and moisture. After reconstitution, store at 2-8°C and use within the timeframe specified by the manufacturer.

Can KORECOA test reconstituted Semaglutide?

Yes, though lyophilized powder generally provides more reliable results. If sending a reconstituted solution, ensure it's properly sealed and shipped with cold packs to maintain stability during transit.